Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
A 26 Week Randomised, Parallel Three-arm, Open-label, Multi-centre, Multinational Treat-to-target Trial Comparing Fixed Ratio Combination of Insulin Degludec and Liraglutide Versus Insulin Degludec or Liraglutide Alone, in Subjects With Type 2 Diabetes Treated With 1-2 Oral Anti-diabetic Drugs (OADs)With a 26 Week Extension
Status: Enrolling
Updated:  2/16/2018
Novo Nordisk Investigational Site
mi
from
Spokane, WA
Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
A 26 Week Randomised, Parallel Three-arm, Open-label, Multi-centre, Multinational Treat-to-target Trial Comparing Fixed Ratio Combination of Insulin Degludec and Liraglutide Versus Insulin Degludec or Liraglutide Alone, in Subjects With Type 2 Diabetes Treated With 1-2 Oral Anti-diabetic Drugs (OADs)With a 26 Week Extension
Status: Enrolling
Updated: 2/16/2018
Novo Nordisk Investigational Site
mi
from
Spokane, WA
Click here to add this to my saved trials
Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
A 26 Week Randomised, Parallel Three-arm, Open-label, Multi-centre, Multinational Treat-to-target Trial Comparing Fixed Ratio Combination of Insulin Degludec and Liraglutide Versus Insulin Degludec or Liraglutide Alone, in Subjects With Type 2 Diabetes Treated With 1-2 Oral Anti-diabetic Drugs (OADs)With a 26 Week Extension
Status: Enrolling
Updated:  2/16/2018
Novo Nordisk Investigational Site
mi
from
Milwaukee, WI
Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
A 26 Week Randomised, Parallel Three-arm, Open-label, Multi-centre, Multinational Treat-to-target Trial Comparing Fixed Ratio Combination of Insulin Degludec and Liraglutide Versus Insulin Degludec or Liraglutide Alone, in Subjects With Type 2 Diabetes Treated With 1-2 Oral Anti-diabetic Drugs (OADs)With a 26 Week Extension
Status: Enrolling
Updated: 2/16/2018
Novo Nordisk Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
A 26 Week Randomised, Parallel Three-arm, Open-label, Multi-centre, Multinational Treat-to-target Trial Comparing Fixed Ratio Combination of Insulin Degludec and Liraglutide Versus Insulin Degludec or Liraglutide Alone, in Subjects With Type 2 Diabetes Treated With 1-2 Oral Anti-diabetic Drugs (OADs)With a 26 Week Extension
Status: Enrolling
Updated:  2/16/2018
Novo Nordisk Investigational Site
mi
from
Broadmeadow,
Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
A 26 Week Randomised, Parallel Three-arm, Open-label, Multi-centre, Multinational Treat-to-target Trial Comparing Fixed Ratio Combination of Insulin Degludec and Liraglutide Versus Insulin Degludec or Liraglutide Alone, in Subjects With Type 2 Diabetes Treated With 1-2 Oral Anti-diabetic Drugs (OADs)With a 26 Week Extension
Status: Enrolling
Updated: 2/16/2018
Novo Nordisk Investigational Site
mi
from
Broadmeadow,
Click here to add this to my saved trials
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea.
Status: Enrolling
Updated:  2/19/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea.
Status: Enrolling
Updated: 2/19/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea.
Status: Enrolling
Updated:  2/19/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea
Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep Apnea.
Status: Enrolling
Updated: 2/19/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Video Games for Obesity and Diabetes Prevention-Diab & Nano
Video Games for Obesity and Diabetes Prevention: Efficacy Trial
Status: Enrolling
Updated:  2/19/2018
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
Video Games for Obesity and Diabetes Prevention-Diab & Nano
Video Games for Obesity and Diabetes Prevention: Efficacy Trial
Status: Enrolling
Updated: 2/19/2018
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/19/2018
Carl T. Hayden VA Medical Center
mi
from
Phoenix, AZ
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/19/2018
Carl T. Hayden VA Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/19/2018
NorthBay Center for Wounds
mi
from
Vacaville, CA
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/19/2018
NorthBay Center for Wounds
mi
from
Vacaville, CA
Click here to add this to my saved trials
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/19/2018
Washington DC VA Medical Center
mi
from
Washington,
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/19/2018
Washington DC VA Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/19/2018
The Research Center
mi
from
Hialeah, FL
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/19/2018
The Research Center
mi
from
Hialeah, FL
Click here to add this to my saved trials
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/19/2018
Advanced Research Institute of Miami
mi
from
Miami, FL
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/19/2018
Advanced Research Institute of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/19/2018
Edward Hines, Jr. VA Hospital
mi
from
Chicago, IL
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/19/2018
Edward Hines, Jr. VA Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/19/2018
Advanced Foot and Ankle Center
mi
from
Las Vegas, NV
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/19/2018
Advanced Foot and Ankle Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/19/2018
Hunter Holmes McGuire VA Medical Center
mi
from
Richmond, VA
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/19/2018
Hunter Holmes McGuire VA Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/19/2018
Salem VA Medical Center
mi
from
Salem, VA
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/19/2018
Salem VA Medical Center
mi
from
Salem, VA
Click here to add this to my saved trials
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  2/19/2018
Avicenne Hospital
mi
from
Bobigny,
Efficacy, Safety and Economic Benefits of Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
A Multi-national, Multi-center, Prospective, Randomized, Double Blinded, Placebo-controlled Trial to Evaluate the Efficacy of HyperBox Cyclical Topical Wound Oxygen Therapy (TWO2) in the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 2/19/2018
Avicenne Hospital
mi
from
Bobigny,
Click here to add this to my saved trials
Optimizing Behavioral Health Homes for Adults With Serious Mental Illness
Optimizing Behavioral Health Homes by Focusing on Outcomes That Matter Most for Adults With Serious Mental Illness
Status: Enrolling
Updated:  2/19/2018
Community Care Behavioral Health Organizations
mi
from
Pittsburgh, PA
Optimizing Behavioral Health Homes for Adults With Serious Mental Illness
Optimizing Behavioral Health Homes by Focusing on Outcomes That Matter Most for Adults With Serious Mental Illness
Status: Enrolling
Updated: 2/19/2018
Community Care Behavioral Health Organizations
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Uncovering the 'ORIGINS' of Diabetes
Uncovering the 'ORIGINS' of Diabetes
Status: Enrolling
Updated:  2/21/2018
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Uncovering the 'ORIGINS' of Diabetes
Uncovering the 'ORIGINS' of Diabetes
Status: Enrolling
Updated: 2/21/2018
Translational Research Institute for Metabolism and Diabetes
mi
from
Orlando, FL
Click here to add this to my saved trials
Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver
Randomized Controlled Trial of Omega-3 Fatty Acids in the Treatment of Non-Alcoholic Steatohepatitis in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  2/22/2018
MetroHealth Med Ctr
mi
from
Cleveland, OH
Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver
Randomized Controlled Trial of Omega-3 Fatty Acids in the Treatment of Non-Alcoholic Steatohepatitis in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 2/22/2018
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver
Randomized Controlled Trial of Omega-3 Fatty Acids in the Treatment of Non-Alcoholic Steatohepatitis in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  2/22/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty Liver
Randomized Controlled Trial of Omega-3 Fatty Acids in the Treatment of Non-Alcoholic Steatohepatitis in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 2/22/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes
Exploration of the Weight Neutral Effects of Insulin Detemir Compared to Insulin Glargine: A Measure of Satiety and Calories Consumed in Type 1 Diabetes
Status: Enrolling
Updated:  2/22/2018
University of New Mexico Health Sciences Center
mi
from
Albuquerque, NM
Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes
Exploration of the Weight Neutral Effects of Insulin Detemir Compared to Insulin Glargine: A Measure of Satiety and Calories Consumed in Type 1 Diabetes
Status: Enrolling
Updated: 2/22/2018
University of New Mexico Health Sciences Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  2/27/2018
Associated Foot & Ankle Specialists, LLC
mi
from
Phoenix, AZ
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2018
Associated Foot & Ankle Specialists, LLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  2/27/2018
Carl t. Hayden Phoenix VA Medical Center
mi
from
Phoenix, AZ
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2018
Carl t. Hayden Phoenix VA Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  2/27/2018
Center for Clinical Research
mi
from
Castro Valley, CA
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2018
Center for Clinical Research
mi
from
Castro Valley, CA
Click here to add this to my saved trials
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  2/27/2018
Valley Vascular Surgery Associates
mi
from
Fresno, CA
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2018
Valley Vascular Surgery Associates
mi
from
Fresno, CA
Click here to add this to my saved trials
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  2/27/2018
Denver VA Medical Center
mi
from
Denver, CO
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2018
Denver VA Medical Center
mi
from
Denver, CO
Click here to add this to my saved trials
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  2/27/2018
Georgetown University Medical Center
mi
from
Washington,
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2018
Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  2/27/2018
Advanced Research Institute of Miami
mi
from
Homestead, FL
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2018
Advanced Research Institute of Miami
mi
from
Homestead, FL
Click here to add this to my saved trials
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  2/27/2018
NewPhase Clinical Trials, Corp.
mi
from
Miami Beach, FL
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2018
NewPhase Clinical Trials, Corp.
mi
from
Miami Beach, FL
Click here to add this to my saved trials
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated:  2/27/2018
Professional Health Care of Pinellas
mi
from
Saint Petersburg, FL
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
An Evaluation of Tissue Engineering Approaches for Treatment of Neuropathic Diabetic Foot Ulcers Resistant to Standard of Care: A Prospective, Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2018
Professional Health Care of Pinellas
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated:  2/27/2018
Carl T. Hayden Veterans Affairs Medical Center
mi
from
Phoenix, AZ
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated: 2/27/2018
Carl T. Hayden Veterans Affairs Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated:  2/27/2018
Dr. Wiliam M. Scholl College of Podiatric Medicine
mi
from
North Chicago, IL
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated: 2/27/2018
Dr. Wiliam M. Scholl College of Podiatric Medicine
mi
from
North Chicago, IL
Click here to add this to my saved trials
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated:  2/27/2018
Endeavor Clinical Trials, PA
mi
from
San Antonio, TX
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated: 2/27/2018
Endeavor Clinical Trials, PA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated:  2/27/2018
UCLA
mi
from
Los Angeles, CA
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated: 2/27/2018
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated:  2/27/2018
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated: 2/27/2018
University of North Carolina School of Medicine
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated:  2/27/2018
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated: 2/27/2018
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated:  2/27/2018
University of Virginia
mi
from
Charlottesville, VA
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated: 2/27/2018
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated:  2/27/2018
University of Wisconsin
mi
from
Madison, WI
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated: 2/27/2018
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated:  2/27/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated: 2/27/2018
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated:  2/27/2018
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated: 2/27/2018
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated:  2/27/2018
Complete Family Foot Care - McAllen Office
mi
from
McAllen, TX
Study of Human Placenta-derived Cells (PDA002) to Evaluate the Safety and Effectiveness in Subjects With PAD and DFU
A Phase 1 Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcer
Status: Enrolling
Updated: 2/27/2018
Complete Family Foot Care - McAllen Office
mi
from
McAllen, TX
Click here to add this to my saved trials
Effects of Resveratrol on Endothelial Function in Type 2 Diabetes Mellitus
Randomized Crossover Study of The Effects of Resveratrol on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  2/27/2018
Boston University Medical Center
mi
from
Boston, MA
Effects of Resveratrol on Endothelial Function in Type 2 Diabetes Mellitus
Randomized Crossover Study of The Effects of Resveratrol on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 2/27/2018
Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Safety, Hemodynamic Effects and Efficacy of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose Range Finding Study to Evaluate the Safety, Hemodynamic Effects and Efficacy of Intramuscular Injection of Human Placenta-derived Cells (Pda-002) in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease
Status: Enrolling
Updated:  2/27/2018
University of Pennsylvania Health Systems
mi
from
Philadelphia, PA
Safety, Hemodynamic Effects and Efficacy of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose Range Finding Study to Evaluate the Safety, Hemodynamic Effects and Efficacy of Intramuscular Injection of Human Placenta-derived Cells (Pda-002) in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease
Status: Enrolling
Updated: 2/27/2018
University of Pennsylvania Health Systems
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Mobile Diabetes Management
Mobile Diabetes Management
Status: Enrolling
Updated:  2/27/2018
University of Maryland, Baltimore
mi
from
Baltimore, MD
Mobile Diabetes Management
Mobile Diabetes Management
Status: Enrolling
Updated: 2/27/2018
University of Maryland, Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Diabetes Prevention Program
Status: Enrolling
Updated:  2/28/2018
George Washington University Biostatistics Center, Suite 750, 6110 Executive Blvd
mi
from
Rockville, MD
Diabetes Prevention Program
Status: Enrolling
Updated: 2/28/2018
George Washington University Biostatistics Center, Suite 750, 6110 Executive Blvd
mi
from
Rockville, MD
Click here to add this to my saved trials
Insulin Resistance and Insulin Secretion
Phenotypic Assessment of Insulin Resistance and Insulin Secretory Capacity
Status: Enrolling
Updated:  2/28/2018
Columbia Presbyterian Medical Center/ Irving Center
mi
from
New York, NY
Insulin Resistance and Insulin Secretion
Phenotypic Assessment of Insulin Resistance and Insulin Secretory Capacity
Status: Enrolling
Updated: 2/28/2018
Columbia Presbyterian Medical Center/ Irving Center
mi
from
New York, NY
Click here to add this to my saved trials
Insulin Resistance and Insulin Secretion
Phenotypic Assessment of Insulin Resistance and Insulin Secretory Capacity
Status: Enrolling
Updated:  2/28/2018
Russ Berrie Pavilion
mi
from
New York, NY
Insulin Resistance and Insulin Secretion
Phenotypic Assessment of Insulin Resistance and Insulin Secretory Capacity
Status: Enrolling
Updated: 2/28/2018
Russ Berrie Pavilion
mi
from
New York, NY
Click here to add this to my saved trials
The Diabetes TeleCare Study
Bridging Barriers to Diabetes Care With Telemedicine: The Diabetes TeleCare Study (DTC)
Status: Enrolling
Updated:  2/28/2018
CareSouth Bennettsville
mi
from
Bennettsville, SC
The Diabetes TeleCare Study
Bridging Barriers to Diabetes Care With Telemedicine: The Diabetes TeleCare Study (DTC)
Status: Enrolling
Updated: 2/28/2018
CareSouth Bennettsville
mi
from
Bennettsville, SC
Click here to add this to my saved trials
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/1/2018
Novo Nordisk Investigational Site
mi
from
Tuscumbia, AL
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/1/2018
Novo Nordisk Investigational Site
mi
from
Tuscumbia, AL
Click here to add this to my saved trials
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  3/1/2018
Novo Nordisk Investigational Site
mi
from
Anaheim, CA
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 3/1/2018
Novo Nordisk Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials